SUB-TYPE: CLASS 4 CAUTION IN USE
Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL.
MHRA Drug alert link: Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd, EL(25)A/32 - GOV.UK
MHRA drug alert date: 1/07/25
p code | Product description | Supplier | Batch Numbers |
90209 | ERYTHROCIN FILMTAB 250MG | Amdipharm UK Ltd | 6104532 |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please email medicalinformation@advanzpharma.com, or telephone +44 (0) 208 588 9131
For stock control enquiries please email custcustomercare@advanzpharma.com or telephone 0208 588 9441
SUB-TYPE: CLASS 3 RECALL
Wockhardt UK Limited is recalling a batch as a precautionary measure following the identification of a dissolution failure during stability testing.
MHRA drug alert date: 30/06/25
Pip code | Product description | Supplier | Batch Numbers |
1048925 | TAMOXIFEN TAB 20MG | WOCKHARDT |
|
1038652 | TAMOXIFEN TAB 20MG MYL | WOCKHARDT | HZ10030 |
1007368 | TAMOXIFEN TAB 20MG WCK | WOCKHARDT |
|
Further Information
For medical information enquiries please email drug.safety@wockhardt.co.uk, or telephone 01978 661261 and ask for ‘drug safety’.
For stock control enquiries please email group_uk_csu@wockhardt.co.uk, or telephone 01978 661261and ask for ‘customer services’.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 3 RECALL
We have received a Class 3 Recall from Glenmark Pharmaceuticals on Omeprazole 20 mg/15 ml Oral Solution
MHRA ref: DMRC-35139406
Reason: Glenmark Pharmaceuticals Europe Ltd is recalling a specific batch of Omeprazole Oral Solution as a precautionary measure due to an investigation following a customer complaint indicating precipitation and discoloration of the product in the bottles. A root cause has identified that this is a result of an inadequate assembly of the plunger stem and the cup which could lead to a premature mixing of the two components of the medicinal product.
Please can you ensure that your stores quarantine the product listed below.
Pip code | Product description | Supplier | Batch Numbers |
8061640 | Omeprazole 20 mg/15 ml Oral Solution | Glenmark Pharmaceuticals | 3230528 |
Further Information
For medical information enquiries please use the following options by phone +44 08004 580 383 or email medical_information@glenmarkpharma.com
For stock control enquiries please email orders.uk@glenmarkpharma.com
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 2 RECALL
A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total vial content is 80mg in 2 mL (with a concentration of 40mg/ml of methylprednisolone acetate).
MHRA drug alert date 25/06/25
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | PI Depo-Medrone 80mg/2mL suspension for injection | Quadrant Pharmaceuticals Limited / Maxearn Limited | LG3883 Max 0943Y |
Further Information
For all medical information enquiries and information on this product, please email maxearnqa@maxearn.co.uk or telephone 01204 471 269.
For stock control enquiries please email maxearnqa@maxearn.co.uk or telephone 01204 471 269.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 3 RECALL
Immunocore Limited is recalling the batches listed below as a precautionary measure. The recall is due to a decrease in potency identified during stability testing. All other stability test results remain within specification.
MHRA drug alert date 25/06/25
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | Kimmtrak 200 micrograms/mL | Immunocore Limited | 3D009AA17 |
Further Information
For all medical information enquiries and information on this product, please email medinfo.eu@immunocore.com, or telephone +442076645100 (local toll) or +00 800-74451111 (toll-free).
For stock control enquiries please email john.sandford@immunocore.com, or telephone +00353(0)858515258.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 2 RECALL
Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton.
MHRA drug alert date 12/06/25
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | PI INHIXA 120MG/0.8ML PFS | Quadrant Pharmaceuticals Limited / Maxearn Limited | 0191Y / AG07093D
9982X / AG11871C |
Further Information
For all medical information enquiries and information on this product, please email eupvg@genreg.eu or telephone 020 7201 0421.
For stock control enquiries please email info@genesis-pharma.com or telephone 0207 201 0400.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states for use in 12 years and older. These general sale packs are intended for use only in adult patients (18 years and over).
MHRA drug alert date: 10/06/25
Pip code | Product description | Supplier | Batch Numbers |
0002691 | DULCOLAX LAXATIVE TABS 5MG | Opella Healthcare UK LTD | See above link |
This is a caution in use only we are not accepting stock returns
Further Information
For all medical information enquiries and information on this product, please email uk-medicalinformation@sanofi.com, or telephone 0800 035 2525.
SUB-TYPE: CLASS 2 RECALL
Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots) as a precautionary measure due to contamination following a small number of complaints of discoloured tablets within the pots.
MHRA drug alert date 09/06/25
Pip code | Product description | Supplier | Batch Numbers |
1018779 | PARACETAMOL TAB 500MG ACC | CHELONIA HEALTHCARE LTD | 2312010 2312011 |
Further Information
For all medical information enquiries and information on this product, please email eupvg@genreg.eu or telephone 020 7201 0421.
For stock control enquiries please email info@genesis-pharma.com or telephone 0207 201 0400.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Zentiva Pharma UK Limited has informed the MHRA of an issue related to batches of various soluble or effervescent tablets.
MHRA drug alert date: 02/06/25
Pip code | Product description | Supplier | Batch Numbers |
8032468 | PARACETAMOL SOL TAB 500MG (24) | ZENTIVA PHARMA UK | See above link |
Alliance do not stock | PARACETAMOL SOL TAB 500MG (100) | ZENTIVA PHARMA UK | See above link |
Alliance do not stock | CO-CODAMOL EFF TAB 8/500MG (32) | ZENTIVA PHARMA UK | See above link |
Alliance do not stock | CO-CODAMOL EFF TAB 8/500MG (100) | ZENTIVA PHARMA UK | See above link |
Alliance do not stock | CO-CODAMOL EFF TAB 30/500MG (100) | ZENTIVA PHARMA UK | See above link |
This is a caution in use only we are not accepting stock returns
Further Information
For all medical information enquiries and information on this product, please email Zentiva medical information via webform, email UKmedinfo@zentiva.com or telephone 0800 090 2408.
For stock control enquiries please email ukcustomerservices@zentiva.com or telephone 08448 793188.
SUB-TYPE: CLASS 2 RECALL
Becton Dickinson UK Ltd has informed the MHRA that some units exhibit an open seal on the packaging of the applicator. This defect could increase the risk of the applicator device being contaminated with pathogens, which could lead to increased infection rates for the patients.
MHRA drug alert date: 19/05/25
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | BD ChloraPrep Clear - 1mL Applicator | Becton Dickinson UK Ltd | See Above link |
Further Information
For all medical information enquiries and information on this product, please email safetyinformation@bd.com, or telephone 08000437546.
For stock control enquiries please email info@insightbio.com, or telephone 01707351330.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.